ARYA Sciences Acquisition V Prices $130M IPO

ARYA Sciences Acquisition V priced its IPO of 13 million Class A ordinary shares at $10 each.

Shares begin trading today on the Nasdaq under ARYE.

ARYA V intends to focus on the healthcare industry in the United States and other developed countries. The company expects to focus on target businesses with valuations of $300 million to $500 million or more and that have the potential for $1 billion or more market capitalization.

Jefferies and Goldman Sachs are joint book-running managers for the offering. The underwriters have a 45-day option to purchase up to an additional 1.95 shares to cover over-allotments, if any.

The offering is expected to close July 15. Read more.

Related Posts
Read More

BCC Investment Files for $300M IPO

The SPAC intends to focus on opportunities primarily in North America, Europe and Asia that complement the sponsor's and management team’s background, especially companies with an established business model and defensible market position.